Palbociclib Capsules 100 Mg

Palbociclib Capsules 100 Mg

Palbociclib Capsules 100 Mg is a targeted anticancer medication classified as a CDK4/6 inhibitor, primarily used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It works by slowing down the growth and division of cancer cells, making it an essential component of modern oncology treatment strategies. In clinical practice, higher strength options such as Palbociclib Capsules 125 Mg may be prescribed based on patient tolerance, while combination hormonal therapies like Letrozole Tablets 2.5 Mg are commonly used alongside Palbociclib to enhance treatment effectiveness.

Mechanism of Action

CDK4/6 Inhibition

Palbociclib Capsules 100 Mg works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which are proteins responsible for regulating cell cycle progression. By blocking these proteins, the medication prevents cancer cells from dividing and multiplying.

Cell Cycle Arrest

This action leads to cell cycle arrest in the G1 phase, effectively slowing tumor growth and progression. For detailed research insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Palbociclib Drug Information.

Approved Medical Uses

Advanced Breast Cancer

Palbociclib Capsules 100 Mg is used in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

Combination Therapy

It is typically prescribed in combination with endocrine therapies to improve treatment outcomes and delay disease progression.

Dosage and Administration

Palbociclib Capsules 100 Mg is usually taken once daily for 21 consecutive days followed by a 7-day break, forming a 28-day treatment cycle. The exact dose depends on patient tolerance and response to therapy. In treatment adjustments, Palbociclib Capsules 125 Mg may be used as an alternative strength, while hormonal combinations often include Letrozole Tablets 2.5 Mg to improve overall therapeutic response.

Clinical Effectiveness

Clinical studies have shown that Palbociclib significantly improves progression-free survival in patients with advanced breast cancer when used in combination with endocrine therapy. It is considered a cornerstone drug in targeted cancer therapy.

Safety and Side Effects

Common Side Effects

• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Hair thinning
• Infections

Serious Risks

• Severe neutropenia leading to infection risk
• Lung inflammation (rare)
• Blood disorders

Regular blood count monitoring is essential during treatment. For more details, refer to Mayo Clinic – Palbociclib Drug Information.

Contraindications and Precautions

Palbociclib Capsules 100 Mg should be used with caution in patients with:

• Low blood cell counts
• Liver impairment
• Active infections

It is not recommended during pregnancy or breastfeeding. Medical supervision is mandatory.

Drug Interactions

Palbociclib Capsules 100 Mg may interact with drugs affecting liver enzymes (CYP3A inhibitors/inducers), certain antibiotics, and antifungal medications. Patients should inform their healthcare provider about all medications they are taking. For research-based data, refer to National Cancer Institute (NCI).

FAQs